Systemic allergic contact dermatitis to 8-methoxypsoralen (8-MOP).
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 11712064.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Photochemotherapy with psoralens and UVA (PUVA) is widely used in the treatment of psoriasis and many other skin conditions. Cutaneous adverse reactions to 8-methoxypsoralen (8-MOP) appear to be rare and may be difficult to distinguish from phototoxicity or UV-induced polymorphic light eruption. We describe a patient who had a systemic allergic contact dermatitis to 8-MOP develop during her second course of PUVA treatment for psoriasis.
Medical subject headings
- Dermatitis, Allergic Contact
- Methoxsalen
- PUVA Therapy
- Psoriasis